Virus versus host: influenza A virus circumvents the immune responses

Graphical abstract


Introduction
Influenza A virus (IAV), a negative-stranded RNA virus containing eight single-stranded RNA segments, belongs to the orthomyxoviridae family and can infect birds, humans, and other mammals.Indeed, IAV infection has become a global risk factor (Richard and Fouchier, 2016), with outbreaks that can cause up to 5 million severe illnesses and up to 500,000 deaths worldwide (Gopal et al., 2020).
The host's innate immunity is the initial line of defense against viral invasion, especially the interferon (IFN) response (Tan et al., 2018).Despite the potent antiviral activity of the innate immune system, it is interesting that viruses, to escape from strong immune responses, have evolved tactics to subvert the host immune repertoire and thereby establish successful infection and proliferation.Antigenic drift, a minor change in the antigenicity of IAV caused by site mutations of surface glycoprotein (either hemagglutinin or neuraminidase), can lead to annual seasonal epidemics (Webby and Webster, 2001), while antigenic shift is to blame the HA or NA recombination events and can generally cause a virus pandemic (Gao et al., 2013).Even healthy young populations vaccinated in advance may have little or no protective immunity when infected with IAV, which significantly increases the mortality rate.
Presently, the effects of immune escape are intricate and multidimensional, and myriad outstanding achievements have been accumulated in existing studies.However, the in-depth immune escape study needs a recent comprehensive content summary highlighting the importance of assessing IAV infection and the immune responses to control and eliminate the infection.Therefore, this review summarizes the latest research on how IAVs evade the host immune system and gain the upper hand in the virus-host game.
Most importantly, this review aims to answer the following research questions: How does IAV elude immune defense?What viral proteins and host factors are involved in this process?On the other hand, it allows researchers to put some order into the current patchwork of studies on immune evasion strategies utilized by IAV.Finally, we discuss some major gaps and unknowns on this subject.
The shape of virus particles is not static, canonically spherical, and a few are filamentous.The surface glycoproteins of virions include HA and NA, and their antigenicity can be used to distinguish and name different virus subtypes.The HA spikes have receptor binding and fusion functions, and NA spikes have receptor-destroying activity.The envelope also contains a third integral membrane protein, M2, which is exposed on the outer surface and functions as an ion channel, essential for uncoating.There are 18 HA subtypes, and 11 NA subtypes unlocked in nature (Yang et al., 2021;Fereidouni et al., 2023).Among these subtypes, there are 3 HA (H1, H2, and H3) and 2 NA (N1 and N2) subtypes of IAV that have occasionally infected humans and caused annual epidemics (Watanabe et al., 2014).
The density and thickness of the M1 protein align with the host cell capsule layer.M1 associates with viral ribonucleoprotein (vRNP) and the virion core and connects with the envelope glycoproteins, HA and NA, to support the virus particle structurally (Schaap and Eghiaian, 2012).The innermost component of the virion is the vRNP complex, composed of vRNA, polymerase proteins, and NP (Moeller et al., 2012).It is characterized by being imported into the cytoplasm for virus assembly and budding at the late stage of the IAV life cycle.

Viral proteins mediate immune escape
The initial response to IAV is directed by the innate immune system, which is triggered by the host's PRRs recognizing viral PAMPs.PRRs are composed of membrane-bound Toll-like receptors (TLRs), cytoplasmic bound retinoic acid inducer I (RIG-I) -like receptors (RLRs), and nucleotide-binding oligomerization domain (Nod) -like receptors (NLRs) (Zhang et al., 2022), mediate viral sensing and activate downstream transcription factors and interferons (IFNs).IFNs initiate immune responses in infected and neighboring cells.The innate immune response releases mounting IFN-stimulated genes (ISGs), leading to the arrest of viral replication (Negishi et al., 2018;Chen et al., 2021).
IAV has evolved multiple strategies to circumvent host immunity to establish successful infection.For example, IAV infection inhibits IFN signaling to reduce IFN production, thus suppressing many antiviral molecules' expression.The suppression of innate immunity by AIV is a sophisticated mechanism and mainly involves a variety of viral proteins (PB1, PB2, PA, NS1, and PB1-F2).

NS1 protein
Non-structural protein 1 (NS1) is considered a pivotal fraction in enhancing virulence by antagonizing the innate antiviral response in various hosts (Figure 2).As stated above, the RIG-I, TLR3, and TLR7 can detect viral RNA in different cell types to induce type I IFN antiviral response upon IAV infection.
NS1 inhibits the activity of RIG-I mainly through direct or indirect influences, enabling the virus to counteract the host antiviral innate immune response successfully (Figures 2A1,A2).For instance, overexpression of CCAAT/enhancer binding protein beta (C/EBPβ) leads to the inhibition of RIG-I expression, while NS1 can promote the phosphorylation process of C/EBPβ and C/EBPβ/NS1 complex occupies the RIG-I promoter, which ultimately promotes viral replication in human lung epithelial cells (Kumari et al., 2020).The pan-handle structure of the vRNA promoter is reckoned to be sensed by RIG-I; the results demonstrated that the mismatched vRNA promoter could affect the formation of the RNA/RIG-I complex and prevent RIG -I activation.In other words, mismatch may represent a general viral strategy to escape RIG-I sensing (Anchisi et al., 2016).IAV can also hijack cellular 5′-3′ exoribonuclease 1 (XRN1) to increase viral titers.IAV NS1 directly interacts with cellular XRN1 and co-localizes in the P-bodies (PBs), and the virus utilizes XRN1 activity to inhibit RIG-I mediated innate immune response (Liu et al., 2021).Additionally, IAV NS1 competitively binds to 14-3-3ε protein with RIG-I to inhibit the translocation of RIG-1 to the adaptor MAVS, leading to insufficient IFN-β production (Wang et al., 2022).
Studies have shown that sphingosine 1-phosphate (S1P) lyase (SPL) enhances the IKKε-mediated type I IFN response, and IAV infection or NS1 protein expression can cause ubiquitination or down-regulation of SPL.Thus, the SPL-mediated antiviral response is subverted (Figure 2B) (Wolf et al., 2021).However, many questions remain unanswered regarding the underlying mechanism of NS1 triggering SPL ubiquitination and degradation.Compared with less virulent seasonal IAV, highly pathogenic avian influenza virus (HPAIV) H5N1, H5N6, and H7N9 can better bypass the innate immune response.Furthermore, through the molecular mechanism of the NS1-SSU72-trans-transcriptional readthrough (TRT)-STAT1/2 axis, AIV infection can reduce the expression of SSU72 and induce TRT, thereby weakening the innate immune response (Figure 2B) (Zhao et al., 2022).Thus, restoring SSU72 expression could be a potential strategy for preventing AIV pandemics.
The NS1 protein can escape innate immunity through amino acid substitution (Figure 2C).The NS1 F9Y amino acid mutation of H1N1 introduced by error-prone PCR can significantly enhance virus growth in vitro and in vivo, increasing virus virulence in mice (Yu et al., 2022).This characteristic mutation can target antiviral drugs and attenuate vaccine development.In addition, the double mutation (R108K/G189D) in the NS1 protein suggested a systematic and selective inhibition of cytokine responses to counteract the innate immune response (Huang et al., 2021).At the same time, the conserved FTEE motif (aa150-153) of NS1 can subvert the RIG-I, TLR3, and TLR7 pathways in combination with TRAF3 E3 ubiquitin ligase to produce type I IFN (Lin et al., 2021).Therefore, the "power" of the virus to antagonize host immunity should not be underestimated by the changes in crucial amino acids.
TLR and NLR significantly contribute to innate immunity against the IAV.The hippo signaling pathway can act as an immune regulator.NS1 binds to the C-terminal domain of the hippo effectors (Yes-associated protein (YAP) and transcriptional coactivator with PDZ-binding motif (TAZ)) YAP/TAZ complex.It activates YAP/TAZ, hijacking the complex into the nucleus.At the same time, YAP/TAZ can downregulate the expression of TLR3 and ultimately block the antiviral innate immune signal, facilitating viral replication and host cell apoptosis (Figure 2D) (Zhang et al., 2022).In addition, NS1 can also interact with tripartite motif-containing protein 25 (TRIM25) through the NLRP3-mediated inflammasome activation pathway.NS1 attenuates the association between pro-caspase-1 and ASC, followed by decreasing

Polymerase proteins
The PB2 protein of RNA polymerase utilizes another key inhibitory mechanism to mediate viral immune evasion.However, the PB2 protein can be localized in the nucleus and mitochondria, and the interaction between PB2 and MAVS can inhibit MAVS mediate IFN-β expression.Still, the PB2 protein of AIV has not been found to have such a phenomenon (Graef et al., 2010).

Novel proteins
PA-X, an overlapping protein-coding region in PA, encodes the N-terminal 191 amino acids and unique C-terminal sequences (41 or 61 amino acid residues) of the PA protein produced by +1 reading frame of the PA gene via ribosomal frameshifting (Jagger et al., 2012).PA-X protein inhibits the expression of chemokine CCL20 to reduce the recruitment of DCs to the nasal epithelial cells (Ecs), which assists the immune evasion of H9N2 subtype AIVs by blocking the downstream innate and mucosal immune activation (Figure 4A) (Qin et al., 2022).Another result showed that PA-X protein inhibited viral replication in chBM-DCs (chicken bone marrow-derived dendritic cells) but not in chicken embryo fibroblast cells (DF-1).Moreover, the PA-X protein downregulated the expression of phenotypic markers (CD40, CD86, and MHC II) and proinflammatory cytokine (IL-12 and IL-1β) of chBM-DCs.Taken together, these findings indicated that PA-X protein is a key viral protein that helps H9N2 subtype AIVs escape the innate immunity of chBM-DCs (Qin et al., 2023).In addition, PA-X acts as a positive viral replication regulator and interacts with host proteins to inhibit IFN expression (Figure 4B) (Rigby et al., 2019;Hu et al., 2020;Li et al., 2021).PB1-F2 is a 90 amino acid protein expressed from the +1 open reading frame in the PB1 gene of IAV (Chen et al., 2001).Recently, it has been reported that PB1-F2 transport to mitochondria by interacting with the Tu translation elongation factor, mitochondria (TUFM), which in turn promotes complete mitophagy.As a result, MAVS is delivered to autophagosomes for degradation, and the type I IFN induction is then suppressed (Wang et al., 2021).Albeit duck and human MAVS share only 28% amino acid similarity, PB1-F2 inhibits both human and avian MAVS signaling to suppress IFN-β induction (Xiao et al., 2020).Of course, there are some exceptions.For example, PB1-F2 of the H7N9 AIV can significantly induce mitochondrial ROS production, accelerate the activation of NLRP3, and negatively regulate virus replication (Pinar et al., 2017).

HA protein
The IAV employs a sophisticated strategy to evade the host's innate immune response, with the HA protein playing a pivotal role.Our investigation sheds light on the intricate mechanisms underlying HA-mediated immune evasion: IFNAR1 (IFN-alpha receptor 1) Degradation by HA1 Protein: • The HA1 subunit of the HA protein orchestrates IFNAR1 ubiquitination, leading to a reduction in IFNAR1 levels within infected cells (Xia et al., 2015).• Remarkably, the abundance of IFNAR1 on the cell surface directly influences cellular sensitivity to interferon-alpha/beta (IFN-α/β) signaling (Kumar et al., 2004(Kumar et al., , 2007;;Zheng et al., 2011).• A comprehensive study delved into the mechanism of IFNAR1 degradation by IAV HA.Intriguingly, HA not only targets IFNAR1 but also degrades the type II interferon (IFN-γ) receptor 1 (IFNGR1) via casein kinase 1α (CK1α).Knockdown of CK1α using small interfering RNA (siRNA) effectively repressed the degradation of both IFNAR1 and IFNGR1 induced by IAV infection (Xia et al., 2015(Xia et al., , 2018)).
Role of PARP1 [Poly (ADP-ribose) polymerase 1] in IFN Receptor Degradation: • Mass spectrometry (MS) studies unveiled the molecular mechanism underlying IFN receptor degradation by IAV HA. • Cellular PARP1 emerges as a critical mediator of IAV HA-induced IFNAR1 degradation.• IAV HA dynamically alters the distribution of endogenous PARP1, facilitating the orchestrated degradation of IFNAR1.This process significantly benefits IAV propagation (Figure 4C) (Xia et al., 2020).
Uncharted Territory: HA and Innate Immune Escape: • Despite these intriguing findings, our understanding of HA's role in innate immune escape remains incomplete.• Further exploration is warranted to unravel the precise mechanisms by which HA orchestrates immune evasion, especially considering its potential impact on pandemic risk.

NP protein
Autophagy is an important cellular process to maintain cellular homeostasis by cleaning up the hazardous substrates in lysosomes.Accumulating research has also suggested that autophagy is a critical mechanism in host defense responses against IAV infection by degrading viral particles and activating innate or acquired immunity to induce viral clearance.However, IAV has conversely hijacked autophagy to strengthen virus infection by blocking autophagy maturation and further interfering with host antiviral signaling to promote viral replication (Krammer et al., 2018).A study revealed that NP-mediated mitophagy leads to the degradation of the mitochondriaanchored protein MAVS, thereby blocking MAVS-mediated antiviral signaling and promoting virus replication.The NP-mediated The progression of PA-X and HA-mediated immune escape of IAV.(A) PA-X protein assisted H9N2 subtype AIVs in escaping immune response of mucosal DCs.The binding of PA-X to CCL20 blocks the recruitment of CD11b + CDs and CD103 + CDs to the nasal mucosa.It downregulates the expression of CCR7 to reduce the expression of CD4 + T cells, which mediates the adaptive immune escape of the virus.(B) PA-X reduces the expression of interferon by inhibiting RIG-I and NF-κB pathways and increases the replication advantage of the virus.(C) The interaction between HA and PARP1 decomposes IFNAR1, inhibits the phosphorylation of STAT1, and then reduces IFN-β, which finally mediates the innate immune escape of the virus.The image was created with BioRender.com.Su et al. 10.3389/fmicb.2024.1394510Frontiers in Microbiology 07 frontiersin.orgmitophagy depends on the NP's interaction with MAVS and the cargo receptor TOLLIP (toll-interacting protein).Moreover, Y313 of NP is a key residue for the MAVS-NP interaction and NP-mediated mitophagy.The NPY313F mutation significantly attenuates the virusinduced mitophagy and the virus replication in vitro and in vivo (Zhang et al., 2023).

Host proteins
IAV utilizes host factors to inhibit the expression of IFNs for efficient transmission, which is the most common way of immune escape (Table 1).N-Myc and STAT (signal transducer and activator of transcription) interactor (NMI) is an IFN-induced protein.Upon IAV infection, NMI recruits the TRIM21 (tripartite motif-containing 21, an E3 ubiquitin ligase) to IRF7 and promotes proteasomal degradation of IRF7.Consequently, NMI impairs the IRF7-induced type I IFN response and facilitates IAV infection (Ouyang et al., 2021).IAV manipulates Src homology region 2-containing protein tyrosine phosphatase 2 (SHP2) to activate the epidermal growth factor receptor (EGFR) signaling pathway, which leads to the downregulation of IFNs and suppression of innate antiviral immunity (Wang et al., 2021).IAV infection upregulates the suppressor of cytokine signaling (SOCS) protein SOCS1, which antagonizes the IFN-activated JAK/STAT signaling pathway by inducing the degradation of JAK1, resulting in suppressed type I and type II IFN responses (Du et al., 2020).Sphingosine kinase 2 (SPHK2), a host sphingolipid metabolism-related factor, interacts with IFN-β promoter through the binding of demethylase TET3 but not with the other promoters regulated by TET3, can in turn recruit HDAC1 to the IFN-β promoter, enhancing the deacetylation of IFN-β promoter, therefore negatively regulating type I IFN expression and thus facilitates IAV propagation (Xu et al., 2022).From RNA interference (RNAi) screening, the double plant homeodomain fingers 2 (DPF2/REQ) gene was identified as one of six genes for which knockdown significantly decreased the infectivity of IAV.DPF2 negatively regulated the induction of the type I IFN and strongly suppressed activation of the JAK/STAT signaling pathway in IAV-infected cells in response to promoting the immune escape of IAV (Shin et al., 2017).As such, PR8 infection specifically induces transcription factor RUNX1, which blocks the expression of IRF3 and STAT1 to attenuate the production of IFN-β and ISGs to facilitate viral infection in A549 cells (Hu et al., 2022).The RNase activity of MCP-1induced protein 1 (MCPIP1) can directly degrade cytokine mRNAs, such as IL-6, IL-12, IL-1β, and IL-2, by functioning as an RNase.The study showed that MCPIP1 reduced RIG-I expression after IAV-infected A549 cells by disrupting the stability of RIG-I mRNA, thereby diminishing the IAV-induced host antiviral response (Sun et al., 2018).
IAV relies on positive cytokines and decreases the activity of NF-κB-related signaling pathways, which is one of the common ways of immune escape.The transcriptional repressor N-myc downstreamregulated gene 1 (NDRG1) facilitates IAV replication by targeting IKKβ and promotes HPAIV H5N1 replication by inhibiting canonical NF-κB activity (Chen et al., 2018).In addition, the sex-determining region Y-box 4 (Sox4) is induced to be up-regulated during IAV infection.Sox4 inhibits the production of MyD88 and most TLRs by

Virus
Host proteins Pathway References binding to their promoters to attenuate gene transcription.In addition, Sox4 blocks the activities of the TLR/MyD88/IRAK4/TAK1 and TLR/ TRIF/TRAF3/TBK1 pathways by repressing their key components.Moreover, Sox4 represses the activation of the NF-κB by interacting with IKKα/β and attenuates NF-kB and IRF3/7 abundances by promoting protein degradation.All these contributed to the downregulation of IFNs and ISG expression, facilitating viral replications and shutting down host immunity to assist IAV (Shang et al., 2021).Notably, the major enzymatic source of ROS, NOX2 oxidase, is activated by a variety of ssRNA and DNA viruses, including IAV, in endocytic compartments, followed by the production of endosomal hydrogen peroxide (H 2 O 2 ), which modifies a unique and highly conserved the cysteine residue (Cys98) of TLR7 to promotes viral replication (To et al., 2017).In addition, proteasome subunit alpha type 2 (PSMA2) is a cellular protein highly expressed in IAV-infected human lung epithelial A549 cells.The result showed that PSMA2 was required for nuclear factor erythroid-2-related factor 2 (NRF2)mediated ROS neutralization and that IAV uses PSMA2 to escape viral clearance via the NRF2-mediated cellular oxidative response (Rashid et al., 2022).Nevertheless, the ROS-dependent regulation of antiviral immunity remains a direction worthy of further exploration.

Non-coding RNAs
IAV can circumvent the host's innate immune system by regulating certain host-long non-coding RNAs (lncRNAs) for their effective propagation (Li et al., 2019;Wang and Cen, 2020).LncNSPL directly binds to RIG-I and blocks the interaction between RIG-I and TRIM25 by reducing TRIM25-mediated lysine 63 (K63)-linked ubiquitination of RIG-I, inhibiting IFN-β activation and reducing the production of antiviral cytokines (Jiang et al., 2022), which is similar to the mechanism mediated by the interaction between NS1 and TRIM25 (Gack et al., 2009).
Increasing evidence has shown that IAV can alter the expression profile of host miRNA (Zhang et al., 2019).Some host miRNAs are involved in various viral infections by regulating type I IFN (Ho et al., 2014).In vitro, miR-221 down-regulation promotes IAV replication by targeting the SOCS1/NF-κB pathway to inhibit type I IFN response (Zhang et al., 2021).Besides, miR-194 can directly target fibroblast growth factor 2 (FGF2), down-regulating FGF2 expression at protein transcription and translation levels to limit IFN response and accelerate H5N1 virus replication (Shi et al., 2020).

IAV escapes from adaptive immune
Host recognition of IAV invasion stimulates innate immune signaling, which leads to the synthesis of numerous effectors and directs the adaptive immune response to the corresponding type of response (Iwasaki and Medzhitov, 2015).Adaptive immunity is the second line of defense against pathogenic microorganisms, including humoral and cellular immunity.
In humoral immunity, the host mainly produces neutralizing antibodies against HA protein.The antibodies bind to HA spherical heads on the virions, inhibiting the attachment of IAV to host cells.In contrast, binding of HA on the surface of infected host cells is required to initiate antibody-dependent cell-mediated cytotoxic effects (ADCC) to eliminate IAV (de Jong et al., 2000).However, antibodies produced against the NA protein have no neutralizing activity, and their major effect is to inhibit NA's enzymatic activity, thereby preventing the release of progeny virions from infected cells (Krammer, 2019).
Cellular immunity is dominated by memory T cells.IAV antigens are presented to CD4 + T cells via major histocompatibility complex (MHC) class II molecules and subsequently activated to produce T helper (Th1) and Th2 cells.Th1 cells express IFN gamma (IFN-γ) and IL-2, which promote the proliferation and differentiation of cytotoxic T lymphocytes (CTLs).Th2 cells express IL-4, IL-5, and IL-13, activating B cells' differentiation and producing specific antibodies.In acquired immunity, DCs are involved in innate immunity and crucial antigen-presenting cells (APCs).DCs present endogenous antigens to CD8 + T cells via MHC class I molecules, capable of activating and differentiating into IAV-specific CTLs.CTLs then migrate to the site of infection, recognizing and eliminating cells infected with multiple IAV subtypes (Ekiert et al., 2011).
Clearance of viral infection by adaptive immunity is mediated by neutralizing antibodies produced by humoral immunity and immune cells produced by cellular immunity.The body produces Th1 immunity to clear the IAV from the lungs (Graham et al., 1994).DCs initiate primary immune responses after recognizing pathogens (Mellman and Steinman, 2001), present antigens to MHC II and MHC I, and up-regulate the expression of costimulatory molecules, which are eventually processed by CD4 + T cells and cytotoxic CD8 + T cells that lyse virus-infected cells and secrete IFN-γ to initiate Th1 immunity (Moran et al., 1999).
Many studies have demonstrated that the substitution of HA protein amino acids is a key determinant of viral antigenic variation (Kaverin et al., 2004;Okamatsu et al., 2008;Ping et al., 2008;Wan et al., 2014;Zhu et al., 2015Zhu et al., , 2022;;Peacock et al., 2016;Jin et al., 2019;Xu et al., 2022;Lyashko et al., 2024), and the antigenic drift of NA may be a by-product of HA (Hensley et al., 2011).The two have co-evolved to assist IAV immune escape.The antigenicity changes of H9N2, H7N9, and H5NX subtype AIVs are pushed by the renewal of vaccine strains and the pressure of antibody selection.Viral evolution promotes viral escape from the neutralization of antibodies by adding N-linked glycosylation (NLG) to shield the antigenic sites, changing virus-antibody binding, or altering the specificity of receptor binding.Adding glycosylation sites at the mutated amino acid sites carried in proteins HA and NA can induce virion escape (Chang and Zaia, 2019;Sealy et al., 2020;Bao et al., 2021;Ge and Ross, 2021;Thornlow et al., 2021).Still, glycosylation is often accompanied by the emergence of compensatory mutations whose function is unknown.Obviously, the exact mechanism of how IAVs escape from adaptive immunity remains to be elucidated (Kosik et al., 2018).

Conclusion and future perspectives
In general, the latest research results on the IAV escaping the host's innate immunity are abundant.We know that IAV uses its proteins and hijacks host proteins as the main means of escape.Recently, various novel viral proteins have been discovered to facilitate virus infection.Still, more studies are needed to explore the roles of these proteins in the IAV infection process and the detailed mechanisms of viral replication and successful antagonism against the host.Moreover, lncRNAs can mediate the antiviral response manipulated by host 10.3389/fmicb.2024.1394510Frontiers in Microbiology 09 frontiersin.orgimmunity (Chen et al., 2021;Yao et al., 2021).Hence, future studies should emphasize how viruses use host lncRNAs for immune escape.
A study identified that the dimerization domain of the SARS-CoV-2 nucleocapsid protein (SARS2-NP) is required for SARS2-NP to undergo liquid-liquid phase separation (LLPS) with RNA, which inhibits Lys63-linked poly-ubiquitination and aggregation of MAVS and thereby suppresses the innate antiviral immune response.Mice infected with an RNA virus carrying SARS2-NP exhibited reduced innate immunity, an increased viral load, and high morbidity (Wang et al., 2021).Future research can explore whether there is a relationship between liquid-liquid phase separation and the immune escape of the IAV.
IAV escaping from acquired immunity is a key "blind area." Viral fitness requires compatibility between HA and NA.So, the IAV needs to change antigenicity so that antibodies cannot neutralize the IAV.Moreover, N-glycosylation of IAV is required for proper viral binding and release (Wagner et al., 2000;Daniels et al., 2003).The glycosylation of HA and NA can interfere with vaccine-induced antibodies by forming steric hindrance (Wagner et al., 2000;Chang and Zaia, 2019), ultimately leading to immune escape of IAV (Hervé et al., 2015).Data suggested that aberrant cellular glycosylation may increase the risk of severe influenza due to the increased ability of glycome-modified IAVs to evade the immune response.Specifically, immunization of mice with NGI-1-treated virus significantly reduced antihemagglutinin and antineuraminidase titers of total serum antibody and reduced hemagglutinin protective antibody responses (Alymova et al., 2022).However, the detailed escape mechanism has yet to be discovered.Indeed, the selection of model viruses is one of the difficulties in studying the immune escape of IAVs.Future studies should explore which adaptive immune signaling pathways are responsible for the failure of antibody neutralization.Only with a better understanding of how IAVs escape from the host immune response can we more effectively develop vaccines and antiviral drugs to achieve the purpose of precise prevention and control of influenza epidemics.

FIGURE 1
FIGURE 1Structure of IAV.The image was created with Adobe Illustrator.

FIGURE 2
FIGURE 2 Schematic diagram of the mechanism of NS1-mediated immune escape in IAV.NS1 mediates the innate immune escape of viruses in five main ways.(A-D) could reduce IFN-β synthesis by inhibiting IFN signaling pathways, thereby circumventing the antiviral effect of host immunity, while E contributes to the immune escape of IAV by inhibiting the inflammatory response pathway.(A1,A2) mainly play the virus against the host by blocking the RIG-I signaling pathway.(B) NS1 mainly acts through host factors (SPL and SSU72) to subvert the antiviral response.(C) The NS1 protein can escape host innate immunity through amino acid substitutions such as single mutation F9Y, double mutation (R108K/G189D), and conserved FTEE motif (aa150-153).(D) NS1 truncation leads to the blocking of TLR production and weakens the antiviral effect.(E) NS1 can also interact with TRIM25 through the NLRP3-mediated inflammasome activation pathway to reduce IL-1β signaling, which may have additional antagonistic effects on host proinflammatory responses and create a favorable environment for viral replication.The image was created with BioRender.com.

FIGURE 3
FIGURE 3 Working model of polymerase acidic proteins-mediated regulation of innate immune escape signal transduction.(A) PB1 delivers MAVS to autophagosomes for degradation through the PB1-RNF5-MAVS-NBR1 axis, blocking RIG-I-MAVS-mediated degradation, ultimately leading to IFN decline and promotion of H7N9 infection.(B) The N-terminal functional domain of PA blocks IRF3 phosphorylation, which is responsible for IFN-β suppression.(C) The ESIE motif can sufficiently antagonize the induction of IFN, which may be associated with the pandemic risk of IAV.The image was created with BioRender.com.

TABLE 1
Summary of host factors involved in innate immune escape in IAV infection.